Gene therapy has potential as a cancer treatment, but significant challenges hinder its practical application. Current gene therapy techniques are rudimentary, often resulting in random gene insertion that can disrupt important genes and potentially induce cancer. This method is primarily effective for severe genetic diseases, but safety concerns have led to suspensions of some clinical trials. Cancer is complex, characterized by multiple mutations rather than a single genetic defect, making it difficult to target effectively. Each cancer case is unique, with different mutations present in individual patients, complicating the development of a one-size-fits-all gene therapy approach. Personalized medicine, which involves profiling a patient's cancer genome to identify specific mutations, is essential for tailoring effective treatments. However, the high cost of DNA sequencing technologies currently limits the feasibility of personalized approaches.Moreover, not all cancer mutations are well understood, which adds another layer of complexity to treatment strategies.